{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:50:13Z","timestamp":1791118213503,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Parasitology"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1016\/j.pt.2004.11.003","type":"journal-article","created":{"date-parts":[[2004,12,15]],"date-time":"2004-12-15T22:07:50Z","timestamp":1103148470000},"page":"58-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"title":["The impact of HIV-protease inhibitors on opportunistic parasites"],"prefix":"10.1016","volume":"21","author":[{"given":"Edoardo","family":"Pozio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Angeles Gomez","family":"Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pt.2004.11.003_bib1","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1126\/science.277.5322.112","article-title":"Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease","volume":"277","author":"Autran","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.pt.2004.11.003_bib2","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/nm0898-953","article-title":"Restoration of cytomegalovirus-specific CD4+ T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1","volume":"4","author":"Komanduri","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.pt.2004.11.003_bib3","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/S0140-6736(97)10291-4","article-title":"Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease","volume":"351","author":"Li","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.pt.2004.11.003_bib4","unstructured":"Anon (2004) Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. http:\/\/AIDSinfo.nih.gov"},{"key":"10.1016\/j.pt.2004.11.003_bib5","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1001\/jama.292.2.251","article-title":"Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-U. S. A. Panel","volume":"292","author":"Yeni","year":"2004","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.pt.2004.11.003_bib6","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators","volume":"338","author":"Palella","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pt.2004.11.003_bib7","unstructured":"Centers for Disease Control and Prevention (2001) HIV\/AIDS surveillance report. US Department of Health and Human Services Public Health Service, Atlanta, Georgia"},{"key":"10.1016\/j.pt.2004.11.003_bib8","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1093\/ije\/31.5.951","article-title":"Changes over calendar time in the risk of specific first AIDS-defining events following HIV seroconversion, adjusting for competing risks","volume":"31","author":"Babiker","year":"2002","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.pt.2004.11.003_bib9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1001\/jama.1997.03540260059037","article-title":"HIV-1 protease inhibitors. A review for clinicians","volume":"277","author":"Deeks","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.pt.2004.11.003_bib10","doi-asserted-by":"crossref","first-page":"13120","DOI":"10.1073\/pnas.95.22.13120","article-title":"An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses","volume":"95","author":"Andre","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pt.2004.11.003_bib11","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/00002030-200004140-00014","article-title":"Highly active antiretroviral therapy inhibits cytokine production in HIV-uninfected subjects","volume":"14","author":"Tovo","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.pt.2004.11.003_bib12","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1099\/0022-1317-49-11-947","article-title":"Infections in AIDS","volume":"49","author":"Hart","year":"2000","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.pt.2004.11.003_bib13","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1046\/j.1365-2249.2002.01941.x","article-title":"Temporary restoration of immune response against Toxoplasma gondii in HIV-infected individuals after HAART, as studied in the hu-PBMC-SCID mouse model","volume":"129","author":"Alfonzo","year":"2002","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.pt.2004.11.003_bib14","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1086\/315471","article-title":"Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis study","volume":"181","author":"Mussini","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.pt.2004.11.003_bib15","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1086\/341306","article-title":"Reactivation of retinal toxoplasmosis despite evidence of immune response to highly active antiretroviral therapy","volume":"35","author":"Stout","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.pt.2004.11.003_bib16","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1128\/CMR.10.2.298","article-title":"Leishmania and human immunodeficiency virus coinfection: the first 10 years","volume":"10","author":"Alvar","year":"1997","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.pt.2004.11.003_bib17","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1086\/344325","article-title":"Impact of highly active antiretroviral therapy on the incidence of visceral leishmaniasis in a French cohort of patients infected with human immunodeficiency virus","volume":"186","author":"del Giudice","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.pt.2004.11.003_bib18","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1128\/JCM.40.3.762-767.2002","article-title":"Incidence of and risk factors for symptomatic visceral leishmaniasis among human immunodeficiency virus type 1-infected patients from Spain in the era of highly active antiretroviral therapy","volume":"40","author":"de la Rosa","year":"2002","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.pt.2004.11.003_bib19","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1086\/318708","article-title":"Influence of highly active antiretroviral therapy on the outcome of subclinical visceral leishmaniasis in human immunodeficiency virus-infected patients","volume":"32","author":"de la Rosa","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.pt.2004.11.003_bib20","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/s100960000364","article-title":"Prospective evaluation and follow-up of European patients with visceral leishmaniasis and HIV-1 coinfection in the era of highly active antiretroviral therapy","volume":"19","author":"Villanueva","year":"2000","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.pt.2004.11.003_bib21","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1080\/00365540151061049","article-title":"Visceral leishmaniasis in an AIDS patient on successful antiretroviral therapy: failure of parasite eradication despite increase in CD4+ T-cell count but low CD8+ T-cell count","volume":"33","author":"Petter","year":"2001","journal-title":"Scand. J. Infect. Dis."},{"key":"10.1016\/j.pt.2004.11.003_bib22","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1053\/jinf.1999.0630","article-title":"Post-kala-azar dermal leishmaniasis during highly active antiretroviral therapy in an AIDS patient infected with Leishmania infantum","volume":"40","author":"Ridolfo","year":"2000","journal-title":"J. Infect."},{"key":"10.1016\/j.pt.2004.11.003_bib23","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1086\/377607","article-title":"Effect of highly active antiretroviral therapy on the incidence and clinical manifestations of visceral leishmaniasis in human immunodeficiency virus-infected patients","volume":"37","author":"Fernandez Cotarelo","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.pt.2004.11.003_bib24","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1086\/516498","article-title":"Clinical cryptosporidiosis and human immunodeficiency virus (HIV)-induced immunosuppression: findings from a longitudinal study of HIV-positive and HIV-negative former injection drug users","volume":"176","author":"Pozio","year":"1997","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.pt.2004.11.003_bib25","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S1286-4579(02)01629-5","article-title":"Cryptosporidiosis: biology, pathogenesis and disease","volume":"4","author":"Tzipori","year":"2002","journal-title":"Microbes Infect."},{"key":"10.1016\/j.pt.2004.11.003_bib26","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1097\/00002030-200307250-00023","article-title":"The diagnostic yield of stool analysis in 525 HIV-1-infected individuals","volume":"17","author":"Datta","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.pt.2004.11.003_bib27","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00126334-200012150-00011","article-title":"Differential impact of combined antiretroviral therapy on the survival of Italian patients with specific AIDS-defining illnesses","volume":"25","author":"Conti","year":"2000","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.pt.2004.11.003_bib28","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/00126334-200010010-00006","article-title":"Eradication of cryptosporidia and microsporidia following successful antiretroviral therapy","volume":"25","author":"Miao","year":"2000","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.pt.2004.11.003_bib29","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1111\/j.1572-0241.2000.03285.x","article-title":"The changing etiology of chronic diarrhea in HIV-infected patients with CD4 cell counts less than 200cells\/mm3","volume":"95","author":"Call","year":"2000","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.pt.2004.11.003_bib30","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1572-0241.2000.01768.x","article-title":"Declining prevalence of opportunistic gastrointestinal disease in the era of combination antiretroviral therapy","volume":"95","author":"Monkemuller","year":"2000","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.pt.2004.11.003_bib31","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1053\/gast.2001.22557","article-title":"Rapid increase of mucosal CD4 T cells followed by clearance of intestinal cryptosporidiosis in an AIDS patient receiving highly active antiretroviral therapy","volume":"120","author":"Schmidt","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pt.2004.11.003_bib32","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0140-6736(97)07529-6","article-title":"Treatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy","volume":"351","author":"Carr","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.pt.2004.11.003_bib33","first-page":"726","article-title":"Resolution of AIDS associated cryptosporidiosis after treatment with indinavir","volume":"92","author":"Grube","year":"1997","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.pt.2004.11.003_bib34","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1086\/323017","article-title":"Opportunistic parasitic infections of the intestinal tract in the era of highly active antiretroviral therapy: Is the CD4+ count so important?","volume":"33","author":"Maggi","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.pt.2004.11.003_bib35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1128\/CMR.10.1.19","article-title":"Biology of Isospora spp. from humans, nonhuman primates and domestic animals","volume":"10","author":"Lindsay","year":"1997","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.pt.2004.11.003_bib36","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S1286-4579(01)01395-8","article-title":"Microsporidiosis: human diseases and diagnosis","volume":"3","author":"Caspar","year":"2001","journal-title":"Microbes Infect."},{"key":"10.1016\/j.pt.2004.11.003_bib37","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00002030-199801000-00005","article-title":"Improvement of chronic diarrhoea in patients with advanced HIV-1 infection during potent antiretroviral therapy","volume":"12","author":"Foudraine","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.pt.2004.11.003_bib38","first-page":"1658","article-title":"Remission of AIDS-associated intestinal microsporidiosis with highly active antiretroviral therapy","volume":"11","author":"Goguel","year":"1997","journal-title":"AIDS"},{"key":"10.1016\/j.pt.2004.11.003_bib39","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/00002030-200303070-00026","article-title":"Remission of disseminated infection caused by Encephalocytozoon intestinalis with highly active antiretroviral therapy","volume":"17","author":"Lafaurie","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.pt.2004.11.003_bib40","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0002-9394(00)00810-2","article-title":"Resolution of microsporidial keratoconjunctivitis in an AIDS patient treated with highly active antiretroviral therapy","volume":"131","author":"Martins","year":"2001","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.pt.2004.11.003_bib41","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1086\/314871","article-title":"In vitro and in vivo anticandidal activity of human immunodeficiency virus protease inhibitors","volume":"180","author":"Cassone","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.pt.2004.11.003_bib42","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1128\/AAC.43.8.2038","article-title":"Effects of the human immunodeficiency virus (HIV) proteinase inhibitors saquinavir and indinavir on in vitro activities of secreted aspartyl proteinases of Candida albicans isolates from HIV-infected patients","volume":"43","author":"Korting","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.pt.2004.11.003_bib43","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1086\/315437","article-title":"In vitro activity of human immunodeficiency virus protease inhibitors against Pneumocystis carinii","volume":"181","author":"Atzori","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.pt.2004.11.003_bib44","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0924-8579(01)00385-5","article-title":"In vitro activity of amprenavir against Pneumocystis carinii","volume":"18","author":"Atzori","year":"2001","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.pt.2004.11.003_bib45","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1086\/323991","article-title":"Anti-human immunodeficiency virus drugs are ineffective against Pneumocystis carinii in vitro and in vivo","volume":"184","author":"Walzer","year":"2001","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.pt.2004.11.003_bib46","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1128\/AAC.44.9.2575-2577.2000","article-title":"Anti-Toxoplasma activities of antiretroviral drugs and interactions with pyrimethamine and sulfadiazine in vitro","volume":"44","author":"Derouin","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.pt.2004.11.003_bib47","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0020-7519(03)00093-6","article-title":"Indinavir reduces Cryptosporidium parvum infection in both in vitro and in vivo models","volume":"33","author":"Mele","year":"2003","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.pt.2004.11.003_bib48","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/jac\/dkg357","article-title":"Effect of antiretroviral protease inhibitors alone, and in combination with paromomycin, on the excystation, invasion and in vitro development of Cryptosporidium parvum","volume":"52","author":"Hommer","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.pt.2004.11.003_bib49","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/00126334-200403010-00002","article-title":"Anti-HIV effects of chloroquine: inhibition of viral particle glycosylation and synergism with protease inhibitors","volume":"35","author":"Savarino","year":"2004","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.pt.2004.11.003_bib50","first-page":"6901","article-title":"Antitumor effect of the human immunodeficiency virus protease inhibitor ritonavir: induction of tumor-cell apoptosis associated with perturbation of proteasomal proteolysis","volume":"62","author":"Gaedicke","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.pt.2004.11.003_bib51","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1086\/322622","article-title":"Incidence and risk factors for toxoplasmic encephalitis in human immunodeficiency virus-infected patients before and during the highly active antiretroviral therapy era","volume":"33","author":"Abgrall","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.pt.2004.11.003_bib52","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1212\/WNL.56.2.257","article-title":"HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990\u20131998","volume":"56","author":"Sacktor","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.pt.2004.11.003_bib53","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1053\/jinf.2001.0810","article-title":"The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART) in a London clinic","volume":"42","author":"Ives","year":"2001","journal-title":"J. Infect."},{"key":"10.1016\/j.pt.2004.11.003_bib54","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0149-2918(98)80031-3","article-title":"Chemotherapeutic agents for human immunodeficiency virus infection: mechanism of action, pharmacokinetics, metabolism, and adverse reactions","volume":"20","author":"Beach","year":"1998","journal-title":"Clin. Ther."}],"container-title":["Trends in Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471492204002892?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471492204002892?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T07:29:14Z","timestamp":1761463754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471492204002892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S1471492204002892"],"URL":"https:\/\/doi.org\/10.1016\/j.pt.2004.11.003","relation":{},"ISSN":["1471-4922"],"issn-type":[{"value":"1471-4922","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of HIV-protease inhibitors on opportunistic parasites","name":"articletitle","label":"Article Title"},{"value":"Trends in Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pt.2004.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}